2026 Annual Meeting (60th)
A big "thank you" to all who helped us celebrate our 60th Annual Meeting!
Quick Links
Event Recap
The Florida Society of Health-System Pharmacists celebrated a major milestone with the FSHP 60th Annual Meeting, held August 7–9, 2026, at the Renaissance Orlando at SeaWorld.
With the theme “Sparkle, Shine, Celebrate!”, the three-day event welcomed more than 930 pharmacists, pharmacy technicians, and pharmacy students for high-quality education, professional development, networking, and a celebration of six decades of advancing pharmacy practice.
Our keynote speaker, Chris Rollins, received a standing ovation for his presentation "Make Moments Matter" about how small moments matter more than we realize. The exhibit hall featured 120 exhibitors showcasing innovative products, services, and resources for pharmacy professionals.
A highlight introduced this year was the “Sparkle Through Sharing” Book Exchange, hosted by the FSHP Professional Affairs Council. The successful new initiative encouraged attendees to exchange professional-development books, share knowledge, and inspire the next generation of pharmacy leaders.
Join us in 2027 at Gaylord Palms in Kissimmee, FL, August 6-8.
Make plans for 2027
Mark your calendar!
August 6-8, 2027
Gaylord Palms Resort
On-Demand CE Recordings Now Available
IMPORTANT: If you claimed CE for any of these sessions from the in-person event, you cannot claim credit for the recorded version.
Posters
Click on a poster title to download it.
Pharmacist & Technician Posters
- 100 | High reliability auditing: pharmacy technician automated dispensing cabinet workflow compliance
- 101 | Digitizing formulary management: a centralized technology-enabled ServiceNow automation workflow
- 102 | Interventions of a telepharmacy service with migraine disorder patients-strengthening the linkage of care between provider and patient
- 103 | Assessment to advice: Preparing future pharmacists for safe and effective self-care recommendations
- 104 | Impact of a pharmacist-led initiative on aspirin deprescribing among hospitalized patients receiving concurrent direct oral anticoagulants with or without P2Y12 inhibitors
- 105 | Cost Savings impact and effectiveness of palonosetron institutional maximum dose of 250 mcg (0.25 mg) in pediatric patients less than 17 years of age when used for prevention of chemotherapy induced nausea and vomiting
- 106 | Implementing an intranasal naloxone program in a community hospital: lessons learned from what worked and what did not
- 107 | Evaluation of a dynamic system list tool to optimize patient care prioritization
- 108 | Comparison of liposomal bupivacaine, multimodal anesthetic cocktails, and traditional local anesthetics for postoperative pain control
- 109 | Weight of the matter: Evaluation of prescribing patterns of semaglutide in patients who are overweight or obese.
- 110 | Basiliximab induction and acute rejection after adult orthotopic heart transplantation
- 111 | Impact of nephrotoxic medication exposure on acute kidney injury rates in pediatric and neonatal patients
- 112 | Comparison of continuous vs symptom-driven hypertonic saline therapy for management of cerebral edema in critically ill adults
Student Posters
- 500 | Review of menstrual suppression strategies and outcomes in women undergoing hematopoietic cell transplantation at Moffitt Cancer Center
- 501 | Medication driven fall risk scoring among adult inpatients experiencing falls during admission
- 502 | Impact of a peer-directed gamified review on exam readiness in a Doctor of Pharmacy curriculum
- 503 | Ketone body-mediated regulation of mitochondrial electron transport complexes via MALAT1 in human cardiomyocytes
- 504 | Functional evaluation of distal cis-acting regulatory elements within the CYP2C locus using CRISPR interference
- 505 | From classroom to career: impact of teaching assistant roles in pharmacy education
- 506 | Implementation gap in chemotherapy dose rounding: A stewardship opportunity for cost avoidance and waste reduction
- 507 | Daily and cumulative opioid use in intensive care unit patients receiving propofol versus dexmedetomidine: a retrospective cohort study
- 508 | Medication management and potential drug interactions during mavacamten therapy in obstructive hypertrophic cardiomyopathy
Award Recipients
Congratulations to all of our 2026 FSHP Award Recipients!
